Rep. Mike Kelly discloses trade(s) in ABT, PEP, DIS
Mike Kelly (PA16) disclosed 3 transactions, traded Jul 17: 0 purchases and 3 sales.
| Traded | Ticker | Company | Action | Amount | Owner |
|---|---|---|---|---|---|
| Jul 17 | ABT | Abbott Laboratories | Sell | $1,001 - $15,000 | Spouse |
| Jul 17 | PEP | Pepsico, Inc. | Sell | $15,001 - $50,000 | Spouse |
| Jul 17 | DIS | Walt Disney Company | Sell | $1,001 - $15,000 | Spouse |
ORIGINAL FILING ↗ALL FILINGS BY MIKE KELLY →CONGRESS TRADES DASHBOARD →
Amounts are the ranges members report. Rows are read automatically from the filing; a trade split across a page break can be missed, so the original filing is the full record.
What This Means
A U.S. House member has filed financial disclosures showing transactions in three large-cap equities spanning healthcare, consumer staples, and media. Congressional stock trading disclosures are public record and tracked by markets observers as a potential signal of insider positioning, though disclosure timing lags execution and does not necessarily indicate current conviction or future direction.
Sources (1)
Every claim below links directly to the original reporting it was drawn from. Penblock synthesizes and cross-references these sources — it doesn't originate the reporting.
- Hon. Mike KellySep 29, 2026View the original filing at the House Clerk ↗
How This Could Play Out
First assessed Sep 29
Resolved
UNLIKELYIf these trades were part of a broader congressional effort to establish clearer insider-trading rules or enhanced disclosure timelines, it could modestly reduce the political-risk premium that some investors attach to holdings of large-cap consumer and healthcare stocks favored by legislators.
Status quo
LIKELYRoutine congressional trading disclosures of this type typically have no measurable market impact, as they reflect ordinary portfolio rebalancing by elected officials and their trusts rather than signals of material non-public information.
Worsens
POSSIBLEShould investigative reporting or regulatory scrutiny reveal a pattern of trades timed to legislative action affecting these sectors, or evidence of information asymmetry, it could intensify scrutiny of congressional trading practices and put downward pressure on confidence in market integrity among retail investors.
SPONSORED
More on Congressional Stock Trading
- Rep. James A. Himes files a Periodic Transaction ReportOct 20
- Rep. Jonathan Jackson discloses trade(s) in DDOG, EL, GH, TYG, VSATOct 19
- Rep. Michael Rulli discloses trade(s) in GOOG, WSBCOct 19
- Attorneys for Ilhan Omar seek return of items taken during home searchOct 17
- Rep. Laurel Lee discloses trade(s) in BAC, NOKBFOct 16
- Rep. Scott H. Peters files a Periodic Transaction ReportOct 15
Get the market digest by email
One email each morning: yesterday's key story and what it means for markets. Free.